Human medicines European public assessment report (EPAR): Hukyndra, adalimumab, Date of authorisation: 15/11/2021, Revision: 11, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 28 January 2026 - 15:32

Human medicines European public assessment report (EPAR): Hukyndra, adalimumab, Date of authorisation: 15/11/2021, Revision: 11, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/hukyndra

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters